European Patent Office

T 1006/21 (B7-H1 in RCC/MAYO FOUNDATION) du 30.01.2024

Identifiant européen de la jurisprudence
ECLI:EP:BA:2024:T100621.20240130
Date de la décision
30 janvier 2024
Numéro de l'affaire
T 1006/21
Requête en révision de
-
Numéro de la demande
05808659.6
Classe de la CIB
G01N 33/574A61K 39/395
Langue de la procédure
Anglais
Distribution
Distribuées aux présidents des chambres de recours (C)
Téléchargement
Décision en anglais
Versions JO
Aucun lien JO trouvé
Autres décisions pour cet affaire
-
Résumés pour cette décision
Résumé de Art 13(2) RPBA 2020
Titre de la demande
B7-H1 and PD-1 in treatment of renal cell carcinoma
Nom du demandeur
Mayo Foundation for Medical Education and Research
Nom de l'opposant
Merck Sharp & Dohme LLC
Janssen Biotech, Inc.
Chambre
3.3.08
Sommaire
-
Dispositions juridiques pertinentes
European Patent Convention Art 111(1)European Patent Convention Art 56European Patent Convention Art 87(1)Rules of procedure of the Boards of Appeal 2020 Art 011
Mots-clés
Inventive step - (no)
Priority - same invention (no)
Remittal - (no)
Exergue
1. The discretionary decision under Article 111(1) EPC to remit a case or not is to be taken ex officio, at any time during the appeal proceedings. It is not dependent on any request by a party. A request for remittal made by a party is therefore not subject to the provisions of Articles 12 and 13 RPBA 2020 (points 23 and 24 of the Reasons).
2. Articles 12 and 13 RPBA 2020 serve to take account of changes in the facts or the subject-matter of the appeal proceedings ("amendments" within the meaning of Articles 12(4) and 13(1) and (2) RPBA), within narrow limits (point 25 of the Reasons).
3. Procedural requests are not amendments within the meaning of Articles 12(4) and 13(1) and (2) RPBA. They can therefore be made at any time during the appeal proceedings and must be considered by the board, regardless of when they are made (points 26 to 29 of the Reasons).

Order

For these reasons it is decided that:

The appeal is dismissed.